Sign up to save your podcasts
Or
Share Cell and Gene Therapy Manufacturing: How 2D Automated Closed Systems are Transforming CGT - Interview with Kolon Biotech
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Cell and Gene Therapy Manufacturing: How 2D Automated Closed Systems are Transforming CGT - Interview with Kolon Biotech
Kolon Biotech's Jungjong Cho believes that the future of cell and gene therapy lies in automation, which offers unprecedented precision and cost efficiencies.
"Traditional manufacturing is prone to human error and variability among operators, affecting the quality of the product," JJ explains. "To overcome these disadvantages, our robotic manipulator significantly reduces these errors and ensures batch-to-batch consistency."
Kolon Biotech is pioneering the use of two innovative technologies that are reshaping manufacturing capabilities:
The 2D Automated Closed Platform represents a quantum leap in manufacturing precision.
The use of 3D Bioreactors further demonstrates the power of scale-up technologies.
Read the full interview
View all episodes
By Life Science NetworksKolon Biotech's Jungjong Cho believes that the future of cell and gene therapy lies in automation, which offers unprecedented precision and cost efficiencies.
"Traditional manufacturing is prone to human error and variability among operators, affecting the quality of the product," JJ explains. "To overcome these disadvantages, our robotic manipulator significantly reduces these errors and ensures batch-to-batch consistency."
Kolon Biotech is pioneering the use of two innovative technologies that are reshaping manufacturing capabilities:
The 2D Automated Closed Platform represents a quantum leap in manufacturing precision.
The use of 3D Bioreactors further demonstrates the power of scale-up technologies.
Read the full interview